查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1133521

全球医学图像分析软件市场-2022-2029

Global Medical Image Analysis Software Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

市场增长受到多种因素的推动，包括医学成像系统的新技术进步、计算机辅助诊断应用的增加以及由于慢性病患病率上升而导致的成像设备使用量增加。

医学成像系统的新兴技术进步将推动市场增长。

医学影像的技术进步，例如人工智能 (AI) 和机器学习 (ML) 的扩展，例如通过 CT 扫描检测中风，限制了中风的治疗时间，因此 AI 可以确定将患者转移到前线并改善结果的特征。扩大使用基于云的建模软件、3D 全息模型。查看完整的解剖细节，包括器官及其内部结构的空间关係，并动态考虑不同结构内的器官血管、肿瘤和异常。这种全息模型有助于术前计划并大大提高手术准确性。此外，通过自动化图像和其他数据的关联和集成，ML 使放射科医师能够自动化放射成像中的查找和解释、质量控制、查找和解释以及剂量估计。此外，POC 帮助放射科医生、护理人员、医生和患者做出数据驱动的决策，以加快诊断和治疗。

严格的 FDA 法规和隐私安全问题预计将抑制全球医学图像分析软件市场的增长。

但是，受 FDA 严格法规的影响，隐私和安全问题将在预测期内阻碍全球市场增长。

COVID-19 影响分析

COVID-19 的影响是一场独一无二的健康危机，对医学图像分析软件市场的全球市场增长产生了巨大影响。 COVID-19 正在为医学图像分析软件市场提供更大的潜力。例如，COVID-19 促使我们重申数字医疗的新现实。这场大流行凸显了对虚拟护理干预的迫切需求，以减少获得医疗保健的障碍。此外，在大流行期间，物理访问一直是一个问题，其中包括不同的平台，例如医学影像分析软件，以抵御任何预期的损害并更快地诊断中风患者。增加对诊断的关注。

内容

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因子
    • 驱动程序
      • 推进技术创新
      • 提高认识
    • 约束因素
      • 高成本
      • 安全和隐私问题
    • 商机
    • 影响分析

第五章行业分析

  • 波特五力分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按应用程序

  • 循环区
  • 肿瘤学
  • 骨科
  • 泌尿科/肾臟科
  • 妇产科
  • 乳房 X 光检查
  • 其他

第 8 章按图像类型

  • 二维图像
  • 3D 图像
  • 4D 图像

第九章技术

  • 磁共振成像 (MRI)
  • 超声成像
  • 计算机断层扫描 (CT)
  • 单光子发射计算机断层扫描 (SPECT)
  • 正电子发射断层扫描 (PET)
  • X 射线诊断成像
  • 组合模式
  • 其他

第十章安装工具

  • 桌面
  • 手机/平板电脑

第 11 章，最终用户

  • 医院和诊所
  • 诊断中心
  • 其他

第 12 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
      • 印度
      • 日本
      • 澳大利亚
      • 其他亚太地区
  • 中东和非洲

第 13 章市场 - 竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 产品基准

第 14 章市场 - 公司简介

  • GE Healthcare
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Philips Healthcare,
  • Toshiba Medical Systems Corporation
  • Siemens Healthineers
  • AGFA Healthcare
  • Esaote S.P.A
  • Mim Software, Inc.
  • Aquilab
  • Carestream Health, Inc.
  • Merge Healthcare Incorporated

第15章 数据

简介目录
Product Code: DMHCIT232

Market Overview

Medical Image Analysis Software Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of YY% during the forecast period (2022-2029).

Medical image analysis software is used to analyze data from medical images aiding diagnosis, compare images between patients or within the same patient at different time points to assess the progress of the disease, and evaluate prognosis.

Market Dynamics

The market growth is driven by several factors, such as the new technological advancements in medical imaging systems, increasing applications of computer-aided diagnosis and increasing use of imaging equipment due to the rising prevalence of chronic diseases.

The new technological advancements in medical imaging systems will drive market growth.

Technological advancements in medical imaging, such as augmentations of artificial intelligence (AI) and machine learning (ML), like in the case of stroke detection through a CT scan, since strokes have a limited treatment window, the AI can identify features that move a patient to the front of the line to improve outcomes, the extended use of cloud-based modeling software, 3D holographic models that displays complete anatomical details, including spatial associations among the organs and their internal structures enabling to consider organ vasculature, neoplasms, and anomalies in-situ within distinct structures. These holographic models benefit in pre-surgery planning and greatly assist surgical precision. Furthermore, ML, through automating the correlation and integration of images with other data, will allow radiologists to detect and interpret findings, control quality, and potentially automate findings, interpretations, and dosage estimation, in radiology imaging. In addition, Point-of-care medical imaging aids radiologists, first responders, physicians, and patients in quickening diagnosis and treatment through data-driven decision-making.

The stringent FDA regulations and privacy & security concerns will restrain the global medical image analysis software market growth.

However, the market is affected by stringent FDA regulations, and privacy and security concerns will hamper the global market growth during the forecast period.

COVID-19 Impact Analysis

The COVID-19 impact is an unparalleled health crisis and has immensely impacted the medical image analysis software market's global market growth. COVID-19 has fed the medical image analysis software market with improved possibilities. For instance, COVID-19 has boosted us to rehearse the new reality of digital care. Amidst the pandemic, it is exposed that there is an urgency for virtual care interventions to reduce compromised access to healthcare. Furthermore, during the pandemic, physical visitations were problematic, which increased the focus on virtual diagnosis involving different platforms such as medical image analysis software to diagnose the patient with stroke faster, dodging any anticipated damage.

Segment Analysis

The cardiology segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The cardiology segment accounted for the largest share and is projected to grow during the forecast period (2022-2029) due to the rising number of cardiac imaging tests as the number of cardiac disorders is increasing and growing advanced and innovative cardiac imaging technologies. For instance, per the World Stroke Organization, more than 13 million people are at risk of a cardiac stroke each year, and 5.5 million will be fatal. The increasing research focus on cardiac imaging tests ensures the cardiology segment's dominance. For instance, the University Hospitals and Case Western Reserve University have been working on an approach to detect heart disease via a chest x-ray. Instead of using one beam of energy, like a typical chest x-ray, their technique employs dual energy technology. Also, there are promising practices in development for higher-quality atherosclerosis imaging, like a high spatial resolution, high signal-to-noise imaging, and quantitative T1/T2 mapping for improved plaque depiction, which will one day allow physicians to peer into vessels to catch the forewarning signs of heart disease much earlier.

Geographical Analysis

The North American region holds the largest market share of the global medical image analysis software market.

North America is predicted to dominate the global market throughout the forecast period (2022-2029) since this region has an increased prevalence of cardiovascular diseases. According to the CDC, in 2020, 0ver 697,000 people in the United States died from heart disease; according to 2020 U.S. data for Out of Hospital Cardiac Arrests (OHCA), survival to hospital discharge was 9.0% for all EMS-treated non-traumatic OHCA cardiac arrests per the American Heart Association (AHA).

Furthermore, the data from the CDC shows that there are nearly 795,000 cases of stroke each year, out of which 18500 strokes are those with stroke history. Also, organizations spreading awareness about cardiovascular diseases contribute to the dominance of the North American region over the global market; a few are the Stroke Organization, National Stroke Association, Stroke Awareness Foundation, and American Stroke Association. In addition, most key market players are U.S. based, such as Mim Software, Inc., G.E. Healthcare, Carestream Health, Inc., Merge Healthcare Incorporated, Etc, which hold a large portion of the market to ensure this region's dominance.

Competitive Landscape

The medical image analysis market is moderately competitive because of the local and global players. Some key players are Philips Healthcare, Toshiba Medical Systems Corporation, GE Healthcare, Siemens Healthineers, AGFA Healthcare, Esaote S.P.A, Mim Software, Inc., Aquilab, Carestream Health, Inc., and Merge Healthcare Incorporated. These key players hold the major share of the market through innovations, product launches, collaborations, acquisitions, and alliances. For instance, in May 09, 2022, Philips received FDA 510(k) clearance for the latest breakthrough high-performance MR 7700 system. Also, in August 16, 2022, Wipro and GE Healthcare Collaborated with Boston Scientific to advance cardiac care in India.

GE Healthcare

Overview:

GE Healthcare is headquartered in Chicago, Illinois, United States, founded in 2004. It is a subsidiary of American Multinational Conglomerate General Electric. It is a leading manufacturer and distributor of diagnostic imaging and radiopharmaceuticals for imaging modalities used in medical imaging procedures.

Product Portfolio:

The product portfolio of GE Healthcare includes Advantage CTC Pro3D EC, AdvantageSim MD AdvantageSim MD, CardEP, Etc.

The global medical image analysis software market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Increasing Innovations
      • 4.1.1.2. Increased Awareness
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost
      • 4.1.2.2. Security and Privacy Concerns
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 7.1.2. Market Attractiveness Index, By Application Segment
  • 7.2. Cardiology
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Oncology
  • 7.4. Orthopedics
  • 7.5. Urology and Nephrology
  • 7.6. Obstetrics and Gynecology
  • 7.7. Mammography
  • 7.8. Others

8. By Image Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Image Type Segment
    • 8.1.2. Market Attractiveness Index, By Image Type Segment
  • 8.2. 2-D Image
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. 3-D Image
  • 8.4. 4-D Image

9. By Technology

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Segment
    • 9.1.2. Market Attractiveness Index, By Technology Segment
  • 9.2. Magnetic Resonance Imaging (MRI)
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Ultrasound Imaging
  • 9.4. Computed Tomography (CT)
  • 9.5. Single-Photon Emission Computed Tomography (SPECT)
  • 9.6. Positron Emission Tomography (PET)
  • 9.7. Radiographic Imaging
  • 9.8. Combined Modalities
  • 9.9. Others

10. By Installation tool

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Installation Tool Segment
    • 10.1.2. Market Attractiveness Index, By Installation Tool Segment
  • 10.2. Desktop
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Mobile/Tablet

11. By End User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 11.1.2. Market Attractiveness Index, By End User Segment
  • 11.2. Hospital And Clinics
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Diagnostic Centers
  • 11.4. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Image Type
    • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Installation tool
    • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. The U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Image Type
    • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Installation tool
    • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. The U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Image Type
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Installation tool
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Image Type
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Installation tool
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 12.5.9. China
      • 12.5.9.1. India
      • 12.5.9.2. Japan
      • 12.5.9.3. Australia
      • 12.5.9.4. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Image Type
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Installation tool
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

13. Market - Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Product Benchmarking

14. Market - Company Profiles

  • 14.1. GE Healthcare
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Philips Healthcare,
  • 14.3. Toshiba Medical Systems Corporation
  • 14.4. Siemens Healthineers
  • 14.5. AGFA Healthcare
  • 14.6. Esaote S.P.A
  • 14.7. Mim Software, Inc.
  • 14.8. Aquilab
  • 14.9. Carestream Health, Inc.
  • 14.10. Merge Healthcare Incorporated

LIST NOT EXHAUSTIVE

15. DataM

  • 15.1. Appendix
  • 15.2. About Us and Services
  • 15.3. Contact Us